Previous Page  10 / 10
Information
Show Menu
Previous Page 10 / 10
Page Background

allied

academies

Page 23

Notes:

Journal of Dermatology Research and Skin Care | Volume 3

Dermatol Res Skin Care, Volume 3

September 09-10, 2019 | Edinburgh, Scotland

2

nd

Global Summit on

3

rd

International Conference on

Dermatology and Cosmetology

Wound Care, Tissue Repair and Regenerative Medicine

Joint Event

&

V

itiligo has always been classified as an autoimmune

disorder since inception. Over the last 10 years,

new theories of its pathogenesis have been entertained

including the low catalase and high hydrogen peroxide in

the skin and many researches done tailored at treatment

modalities. In its presentation, vitiligo is known to affect

any part of the skin that has melanocytes. It therefore

follows that only mucous membranes are spared simply

because they have no melanocytes. The classification of

vitiligo tends to be focused on the pattern of presentation

namely generalised, segmental/dermatomal, acral,

and localized ( focal). It may involve just a small patch

or all the way to widespread involving a big body

surface area. Let's note that when treating infants, they

have a large body surface area (BSA) per body mass

as compared to adults. This translates to absorption

of higher amounts of topical medications. Treatment

modalities range from topical drugs, phototherapy,

laser, surgery and even including some supplements.

Speaker Biography

Peninah Kitili attended University of Nairobi for both undergraduate and

postgraduate (Master's in Paediatrics) degrees in 1978 to 1984 and 1987

to 1990 respectively. She furthered her studies at the University of Vienna

in Austria between 1994 to 1995 where she graduated with a Diploma in

DermatologyandVenereology.Sheworkedatthenationalhospital inKenya

(Kenyatta National, Referral and Teaching Hospital) for 33 years before her

retirement in October 2017. She worked as both consultant paediatrician

and dermatologist. She is the only Paediatrician and Dermatologist in the

country (Kenya) since 1995 but currently expecting one other paediatrician

to join her. She was the head of Department of Dermatology in the hospital

between 2002 upto 2010. She was a member of ethics and research

committee whose role is to guide both undergraduate and postgraduate

students on their researches which is a part fulfilment exercise for their

studies, between 2004 upto 2012 and guided over 500 students. She was a

member of a team that formulated the first ever strategic plan for research

of the university of Nairobi. Also a board member of the American Vitiligo

Research Foundation as a member of the Medical Advisory Committee

(MAC) since 2008 upto date. A member of the Technical Committee of

Cosmetics and related products at the Kenya's bureau of Standards and

includingharmonisationofthesameattheleveloftheEastAfricancountries

(Uganda, Tanzania, Rwanda, Burundi and Kenya). Active member of Kenya

Association of Dermatologists, Kenya Paediatric Association, African

Society of Dermatology and Venereology, European Society of Paediatric

Dermatology among others. Currently she is engaged in full time private

practise in her clinic at the Nairobi hospital, Kenya. Wrote the Dermatology

chapters in 2 books ie a) Guidelines for treatment in healthcare facilities for

the ministry of health in Kenya. b) Guidelines for treatment for healthcare

centres for African Medical Research and Evacuation Foundation (AMREF).

e:

kitilip@gmail.com

Peninah Kitili

Kenyatta National Hospital, Kenya

Treatment of vitiligo on some special body parts